Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
CNSP
#5159
CNS Pharmaceuticals, Inc. Common Stock
2.6
4
USD
+8.64%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+8.64%
Changement Mensuel
+5.60%
Evolution sur 6 mois
-72.36%
Changement Annuel
+120.00%
Clôture Précédente
2.4
3
Open
2.6
4
Bid
Ask
Low
2.6
4
High
2.6
4
Volume
1
Marchés
Actions des Marchés US
Soins de Santé
CNSP
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
28.11
44.48
74.21
354.5
245.37 K
811.45 K
—
Valuation ratios
Enterprise value
31.44 M
23.5 M
-3.72 M
12.41 M
11.59 M
-2.61 M
-18.59 M
Price to earnings ratio
—
—
-0.24
-0.24
-0.15
-0.15
-0.14
Price to sales ratio
—
—
-1 164.33
164.89
12.11 K
-909.61
—
Price to cash flow ratio
—
—
-0.34
-0.32
-0.13
-0.17
-0.24
Price to book ratio
—
—
0.45
-1.01
0.37
0.51
0.57
Enterprise value to EBITDA ratio
-3.38
-1.71
0.21
-0.64
-0.76
0.18
1.28
Profitability ratios
Return on assets %
-0.6
-1.6
-1.17
-11.08
-1.71
-1.84
-1.44
Return on equity %
-0.68
-2.12
-1.88
4.25
-2.41
-3.5
-2.21
Return on invested capital %
-6 290.05
-4 005
-4 206.49
-11.53 K
-15.3 K
-10.5 K
—
Gross margin %
100
—
100
100
100
100
—
Operating margin %
597.26 K
—
490.75 K
-69.39 K
-7.84 M
624.72 K
—
EBITDA margin %
596.66 K
—
490.47 K
-69.27 K
-7.84 M
624.67 K
—
Net margin %
597.47 K
—
490.97 K
-69.33 K
-7.82 M
619.4 K
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
8.13
3.5
2.55
0.26
3.43
1.98
22.95
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
-0
0
-0
0
0
-0
-0
Solvency ratios
Debt to assets ratio
0.03
0.04
0.03
0.18
0.04
0.04
0.06
Debt to equity ratio
0.03
0.06
0.05
-0.07
0.05
0.07
0.1
Long term debt to total assets ratio
0.03
0.04
0.03
0.18
0.04
0.04
0.06
Long term debt to total equity ratio
0.03
0.06
0.05
-0.07
0.05
0.07
0.1
Per share metrics
Operating cash flow per share
—
—
-232.6 K
-112.6 K
-537.25
-31.15
-39.48
EBIT per share
—
—
-336.41 K
-150.01 K
-467.82
-36.06
-44.93
EBITDA per share
—
—
-336.15 K
-149.98 K
-467.72
-36.05
-44.92
Total debt per share
—
—
9 031.88
2 395.35
10.24
0.74
2.05
Cash per share
—
—
221.53 K
4 369.53
202.85
16.24
124.09
Net current asset value per share
—
—
276.81 K
12.67 K
271.82
18.28
137.25
Tangible book value per share
—
—
179.17 K
-35.29 K
193.91
10.2
111.67
Working capital per share
—
—
168.41 K
-36.17 K
192.58
9.03
108.52
Book value per share
—
—
179.17 K
-35.29 K
193.91
10.2
111.67
Nouvelles
CNS Pharmaceuticals se recentre sur des actifs en neurologie et oncologie
CNS Pharmaceuticals shifts focus to neurology, oncology assets
CNS Pharmaceuticals nomme Lynne Kelley directrice médicale
CNS Pharmaceuticals names Lynne Kelley as chief medical officer
CNS Pharmaceuticals appoints three new executives to leadership team
CNS Pharmaceuticals’ new CEO outlines strategic overhaul
Corero Network Security nomme Michelle Ragusa-McBain au poste de directrice des canaux
Corero Network Security annonce des améliorations de sa plateforme de protection DDoS
Corero Network Security reports DDoS protection platform enhancements
L’action de CNS Pharmaceuticals chute après le départ du PDG
CNS Pharmaceuticals stock falls after CEO steps down
CNS Pharmaceuticals appoints Rami Levin as new CEO, replacing Climaco